BALTIMORE, March 17,
2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the
global company behind one of the fastest-growing health and
wellness communities, OPTAVIA®, announced today that
its Board of Directors has declared a $1.64 quarterly cash dividend to its
stockholders. The quarterly cash dividend of $1.64 per share is payable on May 9, 2022 to stockholders of record as of the
close of business on March 29,
2022.
Medifast expects to maintain a program of paying dividends on a
quarterly basis. However, the declaration of dividends in the
future is subject to the discretion of the company's Board of
Directors, who will evaluate the company's dividend program from
time to time based on factors that it deems relevant.
About Medifast®:
Medifast (NYSE: MED) is the global company behind one of
the fastest-growing health and wellness
communities, OPTAVIA®, which offers
scientifically developed products, clinically proven plans and the
support of Coaches and a Community to help Clients
achieve Lifelong Transformation, One Healthy Habit at a
Time®. Based on more than 40 years of experience,
Medifast has redefined direct selling by combining the best aspects
of the model. Its community of independent OPTAVIA
Coaches has impacted more than 2 million lives and teaches Clients
how to develop holistic healthy habits through the proprietary
Habits of Health® Transformational System. Medifast
was recognized in 2020 and 2021 as one of FORTUNE's 100
Fastest-Growing Companies and was named to Forbes' 100
Most Trustworthy Companies in America list in 2017. For more
information,
visit MedifastInc.com or OPTAVIA.com and
follow @Medifast on Twitter.
Forward Looking Statements
Please Note: This release contains "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as
amended, and the Private Securities Litigation Reform Act of 1995.
These forward-looking statements relate to future dividends.
Similarly, descriptions of Medifast's objectives, strategies,
plans, goals or targets contained herein are also considered
forward-looking statements. These statements are based on the
current expectations of the management of Medifast and are subject
to certain events, risks, uncertainties, and other factors. Some of
these factors include, among others, risks associated with
Medifast's direct-to-consumer business model, the impact of rapid
growth on Medifast's systems, disruptions in Medifast's supply
chain, Medifast's inability to continue to develop new services and
products, effectiveness of Medifast's advertising and marketing
programs, including use of social media by independent
OPTAVIA Coaches, Medifast's inability to maintain and grow
the network of independent OPTAVIA Coaches, the departure of
one or more key personnel, Medifast's inability to protect against
online security risks, to protect its brand, to protect against
product liability claims, Medifast's planned growth into domestic
and international markets, adverse publicity associated with
Medifast's products, Medifast's inability to continue declaring
dividends, fluctuations of Medifast's common stock market price,
the impact of the COVID-19 pandemic on Medifast's results, the
severity, length and ultimate impact of COVID-19 on people and
economies, increases in competition, litigation, consequences of
other geopolitical events, natural disasters, acts of war, or
climate change, activist investors, regulatory changes, market
conditions and resulting impact on consumer spending, a failure of
internal control over financial reporting and any limitations
imposed by Medifast's debt agreements. Although Medifast believes
that the expectations, statements, and assumptions reflected in
these forward-looking statements are reasonable, it cautions
readers to always consider all of the risk factors and any other
cautionary statements carefully in evaluating each forward-looking
statement in this release, as well as those set forth in its Annual
Report on Form 10-K for the fiscal year ended December 31, 2021 and other filings filed with
the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
MED-F
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medifast-inc-announces-quarterly-dividend-301505406.html
SOURCE Medifast Inc.